STOCK TITAN

Ideal Power nine-month loss rises 22% to $10.6M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Ideal Power Inc. (IPWR) reported $12,800 in revenue for the nine months ended September 30, 2026, versus $37,728 a year earlier, and a net loss of $10,627,959 versus $8,680,439. Third-quarter revenue was $7,000 versus $24,450, while net loss was $3,583,528 versus $2,940,650. Nine-month revenue came from a distribution partner’s SSCB reference-kit stocking order and shipments under the Stellantis purchase order.

Cash and cash equivalents were $38,270,075 at September 30, 2026, with no outstanding debt. Operating activities used $7,226,693 in the first nine months. The February and May 2026 offerings generated net proceeds of $12.6 million and $27.7 million, respectively, for further commercialization and development of B-TRAN technology and general corporate and working capital purposes.

Ideal Power has launched its discrete B-TRAN and SymCool Power Module, and customers have purchased prototypes in small quantities for evaluation. In October 2026, Power Integrations announced a collaboration with Ideal Power on solid-state circuit breakers. Ideal Power reported a working prototype and work on a reference design for potential customers.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 2 points

How the balance works

Positive

  • None.

Negative

  • Moderate pointNine-month net loss rose 22% to $10,627,959.
  • Minor pointNine-month revenue: $12,800, compared with $37,728 in 2025.

Filing Explained

The 10-Q reports 3,410,086 pre-funded warrants outstanding at September 30, 2026, exercisable at $0.001 each with no expiration, subject to a 9.99% ownership cap; exercise would add shares and reduce existing holders’ percentage ownership, while 16,494,902 common shares were outstanding at quarter-end.

Revenue $12,800 Nine months ended September 30, 2026; $37,728 in the comparable 2025 period
Net loss $10,627,959 Nine months ended September 30, 2026; $8,680,439 in the comparable 2025 period
Revenue $7,000 Three months ended September 30, 2026; $24,450 in the comparable 2025 period
Net loss $3,583,528 Three months ended September 30, 2026; $2,940,650 in the comparable 2025 period
Cash and cash equivalents $38,270,075 At September 30, 2026
Net cash used in operating activities $7,226,693 Nine months ended September 30, 2026
Net proceeds, May 2026 Offering $27.7 million Proceeds to Ideal Power
Net proceeds, February 2026 Offering $12.6 million Proceeds to Ideal Power
pre-funded warrants financial
"pre-funded warrants outstanding"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
anti-dilutive financial
"their effect would be anti-dilutive"
A claim, security feature, or action described as anti-dilutive prevents or does not cause a reduction in existing shareholders’ per-share values when additional shares could be issued. For example, certain convertible securities or corporate actions are treated as anti-dilutive for earnings-per-share calculations if including them would raise EPS rather than lower it; investors watch this because it affects reported per-share metrics, ownership percentages, and valuation comparisons, like keeping pie slices the same size instead of making them smaller.
registered direct offering financial
"in a registered direct offering"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
beneficially owned financial
"beneficially owned by such warrant holder"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Bidirectional bipolar junction TRANsistor technical
"Bidirectional bipolar junction TRANsistor (B-TRAN®) solid-state switch technology"
solid-state circuit breaker technical
"co-develop a B-TRAN®-enabled intelligent solid-state circuit breaker prototype"
A solid-state circuit breaker is an electronic device that controls and interrupts electrical current using fast-acting semiconductor components instead of moving parts. Like a light switch that can react in microseconds and be precisely controlled, it protects equipment and lines from overloads or faults while lasting longer and needing less maintenance than mechanical breakers. Investors care because the technology can reduce downtime, improve safety, and enable smarter, more efficient power systems—features that can lower operating costs and open new markets for manufacturers and service providers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did IPWR report for the third quarter and first nine months of 2026?

IPWR reported $7,000 in revenue for the third quarter and $12,800 for the nine months ended September 30, 2026. The comparable 2025 figures were $24,450 and $37,728, respectively.

What was IPWR’s net loss in the third quarter and first nine months of 2026?

IPWR reported a net loss of $3,583,528 for the third quarter and $10,627,959 for the nine months ended September 30, 2026. The comparable 2025 losses were $2,940,650 and $8,680,439, respectively.

What does IPWR expect for fourth-quarter 2026 research and development expenses?

Ideal Power expects relatively flat quarterly research and development expenses in the fourth quarter of 2026 compared with the third quarter. It said quarterly variation can reflect the timing of semiconductor fabrication runs, hiring and other development activities.

What limit applies to IPWR’s pre-funded warrant exercises?

A holder may exercise pre-funded warrants only to the extent its beneficial ownership immediately after exercise does not exceed 9.99% of IPWR’s outstanding common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Q3 2026 --12-31 false 0001507957 1 NASDAQ 00015079572026-01-012026-09-30 thunderdome:item 00015079572026-07-012026-09-30 xbrli:pure xbrli:shares 0001507957ipwr:PrefundedWarrantsMember2026-01-012026-09-30 iso4217:USD iso4217:USDxbrli:shares 0001507957ipwr:PrefundedWarrantsMember2026-09-30 0001507957ipwr:PrefundedWarrantsMember2025-12-31 utr:Y 0001507957ipwr:The2013EquityIncentivePlanMember2026-01-012026-09-30 0001507957ipwr:The2013EquityIncentivePlanMember2026-09-30 0001507957us-gaap:RestrictedStockUnitsRSUMemberipwr:The2013EquityIncentivePlanMemberipwr:AdvisoryBoardMemberMember2026-01-012026-09-30 0001507957ipwr:PerformanceStockUnitsPSUsMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberipwr:The2013EquityIncentivePlanMember2026-01-012026-09-30 0001507957us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberipwr:The2013EquityIncentivePlanMember2026-01-012026-09-30 0001507957ipwr:PerformanceStockUnitsPSUsMemberipwr:The2013EquityIncentivePlanMembersrt:ExecutiveOfficerMember2026-01-012026-09-30 0001507957us-gaap:RestrictedStockUnitsRSUMemberipwr:The2013EquityIncentivePlanMembersrt:ExecutiveOfficerMember2026-01-012026-09-30 0001507957us-gaap:RestrictedStockUnitsRSUMemberipwr:The2013EquityIncentivePlanMemberipwr:BoardMemberMember2026-01-012026-09-30 0001507957ipwr:PerformanceStockUnitsPSUsMember2026-09-30 0001507957us-gaap:RestrictedStockUnitsRSUMember2026-09-30 0001507957ipwr:PerformanceStockUnitsPSUsMember2026-01-012026-09-30 0001507957us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-30 0001507957ipwr:PerformanceStockUnitsPSUsMember2025-12-31 0001507957us-gaap:RestrictedStockUnitsRSUMember2025-12-31 0001507957ipwr:EquityIncentivePlanMember2026-01-012026-09-30 0001507957ipwr:EquityIncentivePlanMember2026-09-30 0001507957ipwr:EquityIncentivePlanMember2025-01-012025-12-31 0001507957ipwr:EquityIncentivePlanMember2025-12-31 0001507957ipwr:February2026OfferingMember2026-02-012026-02-28 0001507957ipwr:PrefundedWarrantsMember2026-02-28 0001507957ipwr:PrivatePlacementPrefundedWarrantsMember2026-02-282026-02-28 0001507957ipwr:PrivatePlacementPrefundedWarrantsMember2026-02-28 0001507957ipwr:UnderwrittenPublicOfferingPrefundedWarrantsMember2026-02-012026-02-28 0001507957ipwr:UnderwrittenPublicOfferingPrefundedWarrantsMember2026-02-28 0001507957ipwr:February2026OfferingMember2026-02-28 0001507957ipwr:May2026OfferingMember2026-05-012026-05-31 0001507957ipwr:May2026PrefundedWarrantsMember2026-05-31 0001507957ipwr:May2026PrefundedWarrantsMember2026-05-012026-05-31 0001507957ipwr:May2026OfferingMember2026-05-31 0001507957us-gaap:LicensingAgreementsMember2026-09-30 0001507957us-gaap:LicensingAgreementsMember2023-04-30 0001507957us-gaap:LicensingAgreementsMember2015-12-31 00015079572025-01-012025-09-30 00015079572025-07-012025-09-30 utr:M 0001507957ipwr:TempeLeaseMember2026-09-30 0001507957ipwr:AustinLeaseMember2026-09-30 00015079572026-09-30 0001507957ipwr:TempeLeaseMember2026-07-30 0001507957ipwr:TempeLeaseMember2026-07-302026-07-30 0001507957ipwr:TempeLeaseMember2026-01-012026-09-30 utr:sqft 0001507957ipwr:AustinLeaseMember2024-04-30 0001507957ipwr:AustinLeaseMember2024-04-302024-04-30 0001507957ipwr:OfficeAndLaboratorySpaceMember2021-03-31 0001507957ipwr:PatentsYetToBeAwardedMember2025-12-31 0001507957ipwr:PatentsYetToBeAwardedMember2026-09-30 00015079572025-12-31 0001507957us-gaap:OtherIntangibleAssetsMember2025-12-31 0001507957us-gaap:OtherIntangibleAssetsMember2026-09-30 0001507957us-gaap:PatentsMember2025-12-31 0001507957us-gaap:PatentsMember2026-09-30 0001507957us-gaap:TrademarksMember2025-12-31 0001507957us-gaap:TrademarksMember2026-09-30 0001507957ipwr:PrefundedWarrantsMember2019-11-30 0001507957srt:EuropeMember2026-09-30 0001507957srt:AsiaMember2026-09-30 00015079572025-09-30 0001507957us-gaap:RetainedEarningsMember2025-09-30 0001507957us-gaap:TreasuryStockCommonMember2025-09-30 0001507957us-gaap:AdditionalPaidInCapitalMember2025-09-30 0001507957us-gaap:CommonStockMember2025-09-30 0001507957us-gaap:RetainedEarningsMember2025-07-012025-09-30 0001507957us-gaap:TreasuryStockCommonMember2025-07-012025-09-30 0001507957us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001507957us-gaap:CommonStockMember2025-07-012025-09-30 00015079572025-06-30 0001507957us-gaap:RetainedEarningsMember2025-06-30 0001507957us-gaap:TreasuryStockCommonMember2025-06-30 0001507957us-gaap:AdditionalPaidInCapitalMember2025-06-30 0001507957us-gaap:CommonStockMember2025-06-30 00015079572025-04-012025-06-30 0001507957us-gaap:RetainedEarningsMember2025-04-012025-06-30 0001507957us-gaap:TreasuryStockCommonMember2025-04-012025-06-30 0001507957us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-30 0001507957us-gaap:CommonStockMember2025-04-012025-06-30 00015079572025-03-31 0001507957us-gaap:RetainedEarningsMember2025-03-31 0001507957us-gaap:TreasuryStockCommonMember2025-03-31 0001507957us-gaap:AdditionalPaidInCapitalMember2025-03-31 0001507957us-gaap:CommonStockMember2025-03-31 00015079572025-01-012025-03-31 0001507957us-gaap:RetainedEarningsMember2025-01-012025-03-31 0001507957us-gaap:TreasuryStockCommonMember2025-01-012025-03-31 0001507957us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-31 0001507957us-gaap:CommonStockMember2025-01-012025-03-31 00015079572024-12-31 0001507957us-gaap:RetainedEarningsMember2024-12-31 0001507957us-gaap:TreasuryStockCommonMember2024-12-31 0001507957us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001507957us-gaap:CommonStockMember2024-12-31 0001507957us-gaap:RetainedEarningsMember2026-09-30 0001507957us-gaap:TreasuryStockCommonMember2026-09-30 0001507957us-gaap:AdditionalPaidInCapitalMember2026-09-30 0001507957us-gaap:CommonStockMember2026-09-30 0001507957us-gaap:RetainedEarningsMember2026-07-012026-09-30 0001507957us-gaap:TreasuryStockCommonMember2026-07-012026-09-30 0001507957us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-30 0001507957us-gaap:CommonStockMember2026-07-012026-09-30 00015079572026-06-30 0001507957us-gaap:RetainedEarningsMember2026-06-30 0001507957us-gaap:TreasuryStockCommonMember2026-06-30 0001507957us-gaap:AdditionalPaidInCapitalMember2026-06-30 0001507957us-gaap:CommonStockMember2026-06-30 00015079572026-04-012026-06-30 0001507957us-gaap:RetainedEarningsMember2026-04-012026-06-30 0001507957us-gaap:TreasuryStockCommonMember2026-04-012026-06-30 0001507957us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-30 0001507957us-gaap:CommonStockMember2026-04-012026-06-30 00015079572026-03-31 0001507957us-gaap:RetainedEarningsMember2026-03-31 0001507957us-gaap:TreasuryStockCommonMember2026-03-31 0001507957us-gaap:AdditionalPaidInCapitalMember2026-03-31 0001507957us-gaap:CommonStockMember2026-03-31 00015079572026-01-012026-03-31 0001507957us-gaap:RetainedEarningsMember2026-01-012026-03-31 0001507957us-gaap:TreasuryStockCommonMember2026-01-012026-03-31 0001507957us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-31 0001507957us-gaap:CommonStockMember2026-01-012026-03-31 0001507957us-gaap:RetainedEarningsMember2025-12-31 0001507957us-gaap:TreasuryStockCommonMember2025-12-31 0001507957us-gaap:AdditionalPaidInCapitalMember2025-12-31 0001507957us-gaap:CommonStockMember2025-12-31 00015079572026-11-12
 

Tables of Contents


 


 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

OR

 

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to _______________

 

Commission File Number 001-36216

 

IDEAL POWER INC.

(Exact name of registrant as specified in its charter)

 

Delaware

14-1999058

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

 

5508 Highway 290 West, Suite 120

Austin, Texas 78735

(Address of principal executive offices)

(Zip Code)

 

(512) 264-1542

(Registrant’s telephone number, including area code)

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

IPWR

 

The Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b‑2 of the Exchange Act.

 

Large accelerated filer  ☐

Accelerated filer ☐

   

Non-accelerated filer  ☒

Smaller reporting company  ☒

   
 

Emerging growth company  ☐

 

If an emerging growth company, indicate by check mark whether the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the issuer is a shell company (as defined in Rule 12b‑2 of the Exchange Act). Yes ☐ No ☒

 

As of November 12, 2026, the issuer had 16,565,048 shares of common stock, par value $0.001, outstanding.

 


 


 

 

 

  

 

TABLE OF CONTENTS

 

PART I

FINANCIAL INFORMATION

3
     

Item 1.

Unaudited Condensed Financial Statements

3
     
 

Condensed Balance Sheets at September 30, 2026 and December 31, 2025

3
 

Condensed Statements of Operations for the three and nine months ended September 30, 2026 and 2025

4
 

Condensed Statements of Cash Flows for the nine months ended September 30, 2026 and 2025

5
 

Condensed Statements of Stockholders’ Equity for the three-month periods during the nine months ended September 30, 2026 and 2025

6
 

Notes to Unaudited Condensed Financial Statements

7
     

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

13
     

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

16
     

Item 4.

Controls and Procedures

16
     

PART II

OTHER INFORMATION

17
     

Item 1.

Legal Proceedings

17
     

Item 1A.

Risk Factors

17
     

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

17
     

Item 3.

Defaults Upon Senior Securities

17
     

Item 4.

Mine Safety Disclosures

17
     

Item 5.

Other Information

17
     

Item 6.

Exhibits

18
     

SIGNATURES

19

 

2

  

 

PART I-FINANCIAL INFORMATION

 

ITEM 1.  UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

IDEAL POWER INC.

Condensed Balance Sheets

(unaudited)

 

   

September 30,

   

December 31,

 
   

2026

   

2025

 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 38,270,075     $ 6,129,049  

Accounts receivable

    8,200       24,000  

Inventory

    35,750       9,700  

Prepayments and other current assets

    235,848       377,901  

Total current assets

    38,549,873       6,540,650  
                 

Property and equipment, net

    485,651       376,717  

Intangible assets, net

    2,401,874       2,687,466  

Right of use asset

    448,787       397,397  

Other assets

    90,094       44,459  

Total assets

  $ 41,976,279     $ 10,046,689  
                 

LIABILITIES AND STOCKHOLDERS’ EQUITY

               

Current liabilities:

               

Accounts payable

  $ 338,649     $ 408,398  

Accrued expenses

    983,412       471,329  

Current portion of lease liability

    123,955       93,435  

Total current liabilities

    1,446,016       973,162  
                 

Long-term lease liability

    338,622       309,900  

Other long-term liabilities

    806,070       886,538  

Total liabilities

    2,590,708       2,169,600  
                 

Commitments and contingencies (Note 5)

           
                 

Stockholders’ equity:

               

Common stock, $0.001 par value; 50,000,000 shares authorized; 16,496,223 shares issued and 16,494,902 shares outstanding at September 30, 2026 and 8,538,708 shares issued and 8,537,387 shares outstanding at December 31, 2025

    16,496       8,539  

Additional paid-in capital

    168,055,927       125,927,443  

Treasury stock, at cost, 1,321 shares at September 30, 2026 and December 31, 2025

    (13,210 )     (13,210 )

Accumulated deficit

    (128,673,642 )     (118,045,683 )

Total stockholders’ equity

    39,385,571       7,877,089  

Total liabilities and stockholders’ equity

  $ 41,976,279     $ 10,046,689  

 

The accompanying notes are an integral part of these condensed financial statements.

 

3

 

 

IDEAL POWER INC.

Condensed Statements of Operations

(unaudited)

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2026

   

2025

   

2026

   

2025

 

Revenue

  $ 7,000     $ 24,450     $ 12,800     $ 37,728  

Cost of revenue

    9,768       26,069       13,776       60,408  

Gross loss

    (2,768 )     (1,619 )     (976 )     (22,680 )
                                 

Operating expenses:

                               

Research and development

    1,828,068       1,793,162       5,290,515       5,261,173  

General and administrative

    1,613,855       958,938       4,491,838       2,755,998  

Sales and marketing

    475,110       266,598       1,451,642       945,791  

Total operating expenses

    3,917,033       3,018,698       11,233,995       8,962,962  
                                 

Loss from operations

    (3,919,801 )     (3,020,317 )     (11,234,971 )     (8,985,642 )
                                 

Interest income, net

    336,273       79,667       607,012       305,203  
                                 

Net loss

  $ (3,583,528 )   $ (2,940,650 )   $ (10,627,959 )   $ (8,680,439 )
                                 

Net loss per share – basic and diluted

  $ (0.18 )   $ (0.32 )   $ (0.66 )   $ (0.95 )
                                 

Weighted average number of shares outstanding – basic and diluted

    19,859,041       9,153,407       16,015,877       9,124,115  

 

The accompanying notes are an integral part of these condensed financial statements.

 

4

 

 

IDEAL POWER INC.

Condensed Statements of Cash Flows

(unaudited)

 

   

Nine Months Ended

 
   

September 30,

 
   

2026

   

2025

 

Cash flows from operating activities:

               

Net loss

  $ (10,627,959 )   $ (8,680,439 )

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

    295,587       276,332  

Amortization of right of use asset

    75,379       63,908  

Write-off of capitalized patents

    393,459       34,363  

Write-off of property and equipment

    79       6,211  

Stock-based compensation

    2,256,255       997,840  

Decrease (increase) in operating assets:

               

Accounts receivable

    15,800       (30,808 )

Inventory

    (26,050 )     31,319  

Prepaid expenses and other assets

    96,418       147,322  

Increase (decrease) in operating liabilities:

               

Accounts payable

    (69,749 )     125,082  

Accrued expenses and other liabilities

    431,615       116,535  

Lease liability

    (67,527 )     (60,940 )

Net cash used in operating activities

    (7,226,693 )     (6,973,275 )
                 

Cash flows from investing activities:

               

Purchase of property and equipment

    (233,244 )     (111,334 )

Acquisition of intangible assets

    (279,223 )     (265,404 )

Net cash used in investing activities

    (512,467 )     (376,738 )
                 

Cash flows from financing activities:

               

Net proceeds from issuance of common stock and pre-funded warrants

    40,259,375       —  

Exercise of pre-funded warrants

    267       110  

Payment of taxes upon vesting of stock units

    (379,456 )     (98,834 )

Net cash provided by (used in) financing activities

    39,880,186       (98,724 )
                 

Net increase (decrease) in cash and cash equivalents

    32,141,026       (7,448,737 )

Cash and cash equivalents at beginning of period

    6,129,049       15,842,850  

Cash and cash equivalents at end of period

  $ 38,270,075     $ 8,394,113  

 

The accompanying notes are an integral part of these condensed financial statements.

 

5

 

 

IDEAL POWER INC.

Condensed Statements of Stockholders’ Equity

For the Three-Month Periods during the Nine Months Ended September 30, 2026 and 2025

(unaudited)

 

                   

Additional

                           

Total

 
   

Common Stock

   

Paid-In

   

Treasury Stock

   

Accumulated

   

Stockholders’

 
   

Shares

   

Amount

   

Capital

   

Shares

   

Amount

   

Deficit

   

Equity

 

Balances at December 31, 2025

    8,538,708     $ 8,539     $ 125,927,443       1,321     $ (13,210 )   $ (118,045,683 )   $ 7,877,089  

Issuance of common stock and pre-funded warrants, net

    3,505,855       3,506       12,571,171       —       —       —       12,574,677  

Vesting of stock units including payment of employee tax withholdings

    68,876       69       (4,220 )     —       —       —       (4,151 )

Stock-based compensation

    —       —       991,440       —       —       —       991,440  

Net loss

    —       —       —       —       —       (3,631,505 )     (3,631,505 )

Balances at March 31, 2026

    12,113,439       12,114       139,485,834       1,321       (13,210 )     (121,677,188 )     17,807,550  

Issuance of common stock and pre-funded warrants, net

    3,220,961       3,221       27,681,477       —       —       —       27,684,698  

Vesting of stock units including payment of employee tax withholdings

    190,583       190       (253,027 )     —       —       —       (252,837 )

Exercise of pre-funded warrants

    897,858       898       (631 )     —       —       —       267  

Stock-based compensation

    —       —       644,086       —       —       —       644,086  

Net loss

    —       —       —       —       —       (3,412,926 )     (3,412,926 )

Balances at June 30, 2026

    16,422,841       16,423       167,557,739       1,321       (13,210 )     (125,090,114 )     42,470,838  

Vesting of stock units including payment of employee tax withholdings

    73,382       73       (122,541 )     —       —       —       (122,468 )

Stock-based compensation

    —       —       620,729       —       —       —       620,729  

Net loss

    —       —       —       —       —       (3,583,528 )     (3,583,528 )

Balances at September 30, 2026

    16,496,223     $ 16,496     $ 168,055,927       1,321     $ (13,210 )   $ (128,673,642 )   $ 39,385,571  
                                                         

Balances at December 31, 2024

    8,336,812     $ 8,337     $ 125,327,300       1,321     $ (13,210 )   $ (107,467,263 )   $ 17,855,164  

Vesting of stock units including payment of employee tax withholdings

    12,479       12       (9,358 )     —       —       —       (9,346 )

Stock-based compensation

    —       —       384,595       —       —       —       384,595  

Net loss

    —       —       —       —       —       (2,703,024 )     (2,703,024 )

Balances at March 31, 2025

    8,349,291       8,349       125,702,537       1,321       (13,210 )     (110,170,287 )     15,527,389  

Vesting of stock units including payment of employee tax withholdings

    40,044       40       (82,463 )     —       —       —       (82,423 )

Exercise of pre-funded warrants

    110,000       110       —       —       —       —       110  

Stock-based compensation

    —       —       330,030       —       —       —       330,030  

Net loss

    —       —       —       —       —       (3,036,765 )     (3,036,765 )

Balances at June 30, 2025

    8,499,335       8,499       125,950,104       1,321       (13,210 )     (113,207,052 )     12,738,341  

Vesting of stock units including payment of employee tax withholdings

    13,389       14       (7,079 )     —       —       —       (7,065 )

Stock-based compensation

    —       —       283,215       —       —       —       283,215  

Net loss

    —       —       —       —       —       (2,940,650 )     (2,940,650 )

Balances at September 30, 2025

    8,512,724     $ 8,513     $ 126,226,240       1,321     $ (13,210 )   $ (116,147,702 )   $ 10,073,841  

 

The accompanying notes are an integral part of these condensed financial statements.

 

6

 

IDEAL POWER INC.

Notes to Unaudited Condensed Financial Statements

 

 

Note 1 – Organization and Description of Business

 

Ideal Power Inc. (the “Company”) was incorporated in Texas in May 2007 under the name Ideal Power Converters, Inc. The Company changed its name to Ideal Power Inc. and re-incorporated in Delaware in July 2013. With headquarters in Austin, Texas, the Company is focused on the further development and commercialization of its Bidirectional bipolar junction TRANsistor (B-TRAN®) solid-state switch technology.

 

Since its inception, the Company has financed its research and development efforts and operations primarily through the sale of common stock and pre-funded warrants. The Company’s continued operations are dependent upon, among other things, its ability to obtain adequate sources of funding through future revenues, follow-on stock offerings, issuances of warrants, debt financing, co-development agreements, government grants, sale or licensing of developed intellectual property or other alternatives.

 

 

Note 2 – Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed balance sheet at December 31, 2025 has been derived from the Company’s audited financial statements included in its Annual Report on Form 10-K filed with the SEC on March 27, 2026.

 

In the opinion of management, these condensed financial statements reflect all normal recurring, and other adjustments, necessary for a fair presentation. These condensed financial statements should be read in conjunction with the audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year or any other future periods.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Segment Information

 

Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s Chief Executive Officer is the Company’s CODM. The CODM reviews financial information presented on a company-wide basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. As such, the Company has determined that it operates as one operating segment. The Company has concluded that net income (loss) is the measure of segment profitability. The CODM assesses performance for the Company, monitors budget versus actual results and determines how to allocate resources based on net income (loss) as reported in the condensed statements of operations. There are no other expense categories regularly provided to the CODM that are not already included in the condensed financial statements herein.

 

During the nine months ended September 30, 2026 and 2025, the Company did not generate material international revenues. At September 30, 2026, the Company had $125,044 and $1,465 in property and equipment, net located in Asia and Europe, respectively.

 

Net Loss Per Share

 

In accordance with Accounting Standards Codification (“ASC”) 260, shares issuable for little or no cash consideration are considered outstanding common shares and included in the computation of basic net loss per share. As such, for the three and nine months ended September 30, 2026 and 2025, respectively, the Company included pre-funded warrants to purchase shares of common stock in its computation of net loss per share. The pre-funded warrants were issued in May 2026, February 2026, March 2024 and November 2019 with an exercise price of $0.001. See Note 8.

 

7

 

In periods with a net loss, no common share equivalents are included in the computation of diluted net loss per share because their effect would be anti-dilutive. At September 30, 2026 and 2025, potentially dilutive shares outstanding amounted to 1,180,935 and 824,760 shares, respectively, and exclude pre-funded warrants to purchase shares of common stock.

 

Recent Accounting Pronouncements

 

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures, which mandates enhanced disclosure of specific costs and expenses within the notes to the financial statements. In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03. The guidance is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments may be applied prospectively to reporting periods after the effective date or retrospectively to all periods presented in the financial statements. The Company is currently evaluating the impact that this ASU will have on the presentation of its condensed financial statements. 

 

 

Note 3 – Intangible Assets, Net

 

Intangible assets, net consisted of the following:

 

   

September 30,

   

December 31,

 
   

2026

   

2025

 

Patents

  $ 1,938,902     $ 2,062,262  

Trademarks

    35,653       26,529  

Other intangible assets

    1,843,036       1,843,036  
      3,817,591       3,931,827  

Accumulated amortization - patents

    (498,003 )     (430,710 )

Accumulated amortization - other intangible assets

    (917,714 )     (813,651 )
    $ 2,401,874     $ 2,687,466  

 

At September 30, 2026 and December 31, 2025, the Company capitalized $440,900 and $723,156, respectively, for costs related to patents that have not been awarded. Costs related to patents that have not yet been awarded are not amortized until patent issuance.

 

Amortization expense amounted to $58,073 and $171,356 for the three and nine months ended September 30, 2026, respectively, and $55,253 and $164,652 for the three and nine months ended September 30, 2025, respectively. Amortization expense for the succeeding five years and thereafter is $58,405 (remaining three months of 2026), $233,621 (2027-2030) and $932,432 (thereafter).

 

The Company conducted an evaluation and rationalization of its patent portfolio and recorded non-cash impairment charges of $178,326 and $393,459 for the three and nine months ended September 30, 2026, respectively. The impairment charges are included in general and administrative expenses.

 

Costs related to indefinite life trademarks are not amortized but are subject to evaluation for potential impairment.

 

 

Note 4 – Lease

 

In April 2024, the Company entered into a first amendment and relocation agreement (the “Austin Lease”) with its landlord. The Austin Lease is for 5,775 square feet of office and laboratory space located in Austin, Texas and, upon occupancy, replaced the 4,070 square feet of office and laboratory space previously leased by the Company. The term of the Austin Lease expires sixty-two (62) months from July 1, 2024, the commencement date. The annual base rent for the first year of the Austin Lease was $118,388 and the annual base rent increases approximately 2.75% each year during the lease term. The Company is required to pay its proportionate share of operating costs for the building under this triple net lease.

 

The Company recognized a non-cash right of use asset of $524,025 and a corresponding lease liability for the Austin Lease on the commencement date. For purposes of calculating the right of use asset and lease liability, the Company estimated its incremental borrowing rate at 8.5% per annum.

 

In July 2026, the Company entered into an office lease agreement (the “Tempe Lease”) for 2,550 square feet of office space located in Tempe, Arizona. The commencement date of the Tempe Lease was August 1, 2026, and the term is thirty-nine (39) months from the commencement date. Under the Tempe Lease, the first three months of lease payments were abated, and the Company was also granted a $31,000 rent credit to be applied after the expiration of the rent abatement. Upon expiration of the abatement period, the annual base rent and operating costs for the first year of the lease is $86,700, exclusive of the rent credit, split between base rent of $52,198 and operating costs of $34,502. The annual base rent and operating costs (subject to adjustment annually) increase 3% per year over the term of the lease and are subject to rental tax.

 

8

 

The Company recognized a non-cash right of use asset of $126,769 and a corresponding lease liability for the Tempe Lease on the commencement date. For purposes of calculating the right of use asset and lease liability, the Company estimated its incremental borrowing rate at 6.5% per annum.

 

Future minimum payments under the two leases are as follows:

 

For the Year Ended December 31,

       

2026 (remaining)

  $ 35,593  

2027

    165,269  

2028

    184,230  

2029

    134,725  

Total lease payments

    519,817  

Less: imputed interest

    (57,240 )

Total lease liability

    462,577  

Less: current portion of lease liability

    (123,955 )

Long-term lease liability

  $ 338,622  

 

At September 30, 2026, the remaining lease term for the Austin Lease was 35 months and the remaining lease term for the Tempe Lease was 37 months.

 

For the three months ended September 30, 2026 and 2025, operating cash outflows for lease payments totaled $31,243 and $30,405, respectively, and for the nine months ended September 30, 2026 and 2025, operating cash outflows for lease payments totaled $92,054 and $89,599, respectively. For the three months ended September 30, 2026 and 2025, operating lease cost, recognized on a straight-line basis, totaled $38,194 and $30,856, respectively, and for the nine months ended September 30, 2026 and 2025, operating lease cost, recognized on a straight-line basis, totaled $99,906 and $92,568, respectively. 

 

 

Note 5 – Commitments and Contingencies

 

License Agreements

 

In 2015, the Company entered into a licensing agreement which expires in February 2033. Per the agreement, the Company has an exclusive royalty-free license, included in intangible assets, associated with semiconductor power switches which enhances its intellectual property portfolio. The Company pays $100,000 annually under this agreement.

 

In 2023, the Company amended a 2021 license agreement which expires in February 2034. Per the agreement, the Company has an exclusive royalty-free license, included in intangible assets, associated with semiconductor drive circuitry which enhances its intellectual property portfolio. The Company pays $50,000 annually under this agreement.

 

At September 30, 2026, the estimated present value of future payments under the licensing agreements was $956,070 with $150,000 due and payable in the next twelve months ($806,070 recognized in other long-term liabilities and $150,000 in accrued expenses). The Company is accruing interest for future payments related to these agreements.

 

Legal Proceedings

 

The Company is subject to litigation from time to time. While the Company believes that any current or threatened legal proceedings are without merit and not material, there can be no assurance that such matters will not have a material adverse effect on its business, financial condition or results of operations in the future.

 

Indemnification Obligations

 

The employment agreements of Company executives include an indemnification provision whereby the Company shall indemnify and defend, at the Company’s expense, its executives so long as an executive’s actions were taken in good faith and in furtherance of the Company’s business and within the scope of the executive’s duties and authority.

 

 

Note 6 – Common Stock

 

In May 2026, the Company issued and sold 3,220,961 shares of its common stock at a price of $5.67 per share and 2,070,044 pre-funded warrants to purchase shares of common stock at a price of $5.669 per pre-funded warrant in a registered direct offering (the “May 2026 Offering”). The pre-funded warrants have an exercise price of $0.001 per share, are immediately exercisable, and have no expiration date. The net proceeds to the Company from the May 2026 Offering were $27.7 million.

 

9

 

In February 2026, the Company issued and sold 3,505,855 shares of its common stock at a price of $2.75 per share and 952,881 pre-funded warrants to purchase shares of common stock at a price of $2.749 per pre-funded warrant in an underwritten public offering, and also sold 631,332 pre-funded warrants to purchase shares of common stock at a price of $2.749 per pre-funded warrant in a concurrent private placement (taken together, the “February 2026 Offering”). The shares of common stock underlying the pre-funded warrants issued in the concurrent private placement were subsequently registered for resale on the Registration Statement on Form S-1 (File No. 333-294696) declared effective on April 3, 2026. The pre-funded warrants have an exercise price of $0.001 per share and no expiration date. The net proceeds to the Company from the February 2026 Offering were $12.6 million.

 

 

Note 7 – Equity Incentive Plan

 

In May 2013, the Company adopted the 2013 Equity Incentive Plan (as amended and restated, the “Plan”) and reserved shares of common stock for issuance under the Plan, which was last amended in June 2026. The Plan is administered by the Compensation Committee of the Company’s Board of Directors (the “Board”). At September 30, 2026, 851,916 shares of common stock were available for issuance under the Plan.

 

A summary of the Company’s stock option activity and related information is as follows:

 

                   

Weighted

 
           

Weighted

   

Average

 
           

Average

   

Remaining

 
   

Stock

   

Exercise

   

Life

 
   

Options

   

Price

   

(in years)

 

Outstanding at December 31, 2025

    370,814     $ 7.48       2.6  

Forfeited/Expired

    (42,431 )   $ 17.39          

Outstanding at September 30, 2026

    328,383     $ 6.20       1.9  

 

All outstanding stock options were exercisable at September 30, 2026.

 

A summary of the Company’s restricted stock unit (“RSU”) and performance stock unit (“PSU”) activity is as follows:

 

   

RSUs

   

PSUs

 

Outstanding at December 31, 2025

    645,557       357,438  

Granted

    298,817       70,000  

Vested

    (176,188 )     (156,653 )

Forfeited

    (126,852 )     (59,567 )

Outstanding at September 30, 2026

    641,334       211,218  

 

During the nine months ended September 30, 2026, the Company granted 90,910 RSUs to Board members, 20,000 RSUs and 20,000 PSUs to executives, 177,806 RSUs and 50,000 PSUs to employees, and 10,101 RSUs to an advisory board member under the Plan. The estimated fair value of these equity grants was $1,514,212, of which $476,770 was recognized in stock-based compensation expense totaling $2,256,255 for the nine months ended September 30, 2026.

 

At September 30, 2026, there was $2,584,674 of unrecognized compensation cost related to non-vested equity awards. That cost is expected to be recognized over a weighted average period of 1.1 years.

 

 

Note 8 – Pre-Funded Warrants

 

At September 30, 2026 and December 31, 2025, the Company had 3,410,086 and 653,827 pre-funded warrants outstanding, respectively, with an exercise price of $0.001 per share and no expiration date.

 

During the nine months ended September 30, 2026, a warrant holder exercised 266,666 pre-funded warrants for exercise proceeds of $267 and a warrant holder exercised 631,332 pre-funded warrants on a cashless basis, receiving 631,192 shares of the Company’s common stock with 140 shares of the Company’s common stock forfeited to cover the exercise price.

 

At September 30, 2026, all pre-funded warrants were exercisable, although the pre-funded warrants may be exercised only to the extent that the total number of shares of common stock then beneficially owned by such warrant holder does not exceed 9.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such exercise.

 

10

  

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION CONTAINED IN THIS REPORT

 

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These statements include, but are not limited to, statements regarding our future financial performance, liquidity, business condition and results of operations, expectations regarding future expenses and gross margins, future business plans, and expectations regarding design wins and other business developments. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. You can find many (but not all) of these statements by looking for words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “would,” “should,” “could,” “may” or other similar expressions in this report. In particular, these include statements relating to future actions, prospective products, applications, customers, technologies, future performance or results of anticipated products, expenses, and financial results. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections. Factors that could cause actual results to differ from those discussed in the forward-looking statements include, but are not limited to:

 

 

●

our history of losses;

 

 

●

our ability to generate revenue;

 

 

●

our limited operating history;

 

 

●

the size and growth of markets for our technology;

 

 

●

regulatory developments that may affect our business;

 

 

●

our ability to successfully develop new products and the expected performance of those products;

 

 

●

the performance of third-party consultants and service providers whom we have and will continue to rely on to assist us in development and commercialization of our B-TRAN® and related packaging and drive circuitry;

 

 

●

the rate and degree of market acceptance for our B-TRAN® and current and future B-TRAN® products;

 

 

●

the time required for third parties to redesign, test and certify their products incorporating our B-TRAN®;

 

 

●

our ability to successfully commercialize our B-TRAN® technology;

 

 

●

our ability to secure strategic partnerships with semiconductor fabricators and others related to our B-TRAN® technology;

 

 

●

our ability to obtain, maintain, defend and enforce intellectual property rights protecting our technology;

 

 

●

the success of our efforts to manage cash spending, particularly prior to the commercialization of our B-TRAN® technology at scale;

 

 

●

trade protectionism, tariffs, and other barriers to trade that impact the availability or cost of the raw materials and components used in our products;

   

 

 

●

general economic conditions and events, including inflation, and the impact they may have on us and our potential partners and licensees;

 

 

●

our dependence on the global supply chain and impacts of supply chain disruptions;

 

 

●

our ability to obtain adequate financing in the future, if and when we need it;

 

 

●

the impact of global health pandemics on our business, financial condition and results of operations;

 

 

●

our success at managing the risks involved in the foregoing items; and

 

11

 

 

●

other factors discussed in this report.

 

The forward-looking statements are based upon management’s beliefs and assumptions and are made as of the date of this report. We undertake no obligation to publicly update or revise any forward-looking statements included in this report, except as required by applicable law. You should not place undue reliance on these forward-looking statements.

 

Unless otherwise stated or the context otherwise requires, the terms “Ideal Power,” “we,” “us,” “our” and the “Company” refer to Ideal Power Inc.

 

12

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q as well as our audited 2025 financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2025. In addition to historical information, the discussion and analysis here and throughout this Form 10-Q contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including, but not limited, to those set forth under “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025.

 

Overview

 

Ideal Power Inc. is located in Austin, Texas. We are solely focused on the further development and commercialization of our Bidirectional bipolar junction TRANsistor (B-TRAN®) solid-state switch technology.

 

To date, operations have been funded primarily through the sale of common stock and pre-funded warrants.

 

We are in the process of commercializing our B-TRAN® technology and have launched our first two commercial products, the discrete B-TRAN® and the SymCool® Power Module. We generated $12,800 in revenue in the nine months ended September 30, 2026 and $37,728 in revenue in the nine months ended September 30, 2025.

 

Product Launches

 

Our first commercial product launch was the discrete B-TRAN®. This single B-TRAN® die packaged for electrical connection is designed to meet the very low conduction loss needs of the solid-state circuit protection and electric vehicle (“EV”) contactor markets.

 

Our second commercial product launch was the SymCool® Power Module. This multi-die B-TRAN® module is also designed to meet the very low conduction loss needs of the solid-state circuit protection and EV contactor markets.

 

Upon product launch, we design and build initial prototypes for testing and to solicit customer feedback. Based on the results of testing and customer feedback, we incorporate any necessary changes into the product design, build final prototypes and complete additional testing prior to full commercial release. To date, our customers have purchased prototypes in small quantities for evaluation and provided us feedback that has been incorporated into our product designs. We expect significantly higher volume orders from customers once we secure a design win from them and they start to build inventory in advance of launching their OEM products. For the products described above, we would expect the time from announcing a design win to the sale of the related OEM product to be roughly twelve to eighteen months, although it may vary considerably depending on the customer and application. We would expect a significantly longer design cycle for automotive applications. Design wins are expected to result in significant revenue growth for us over time as product life cycles tend to be relatively long for power electronics products as changing to another technology would require an OEM to redesign their product.

 

Development Agreement

 

In 2022, we announced, and began the first phase of, a product development agreement with Stellantis, a top 10 global automaker, for a custom B-TRAN® power module for use in the automaker’s EV drivetrain inverters in its next generation EV platform. In the first phase of the program, we provided packaged B-TRAN® devices, test kits and technical data to Stellantis for their evaluation. In 2023, we secured, and began the second phase of, this program. In the second phase of the program, we collaborated with Stellantis and the program partners, including both the program’s packaging company and the organization building the initial drivetrain inverter, to supply B-TRAN® devices for integration into the custom power module and inverter designs. Also, as part of the second phase of the program, we provided Stellantis a comprehensive test plan for the testing required to achieve certification to automotive standards for B-TRAN®. The test plan was subsequently approved as submitted. In 2024, we successfully completed the second phase of the program. In August 2025, we secured an order from Stellantis for custom development and packaged devices targeting multiple EV applications. We completed the first deliverable under this purchase order in 2025. Also in 2025, Stellantis informed us that they are prioritizing the EV contactor application over the drivetrain inverter application. In 2026, we delivered next generation B-TRAN® custom-packaged samples and development kits for evaluation to Stellantis for EV applications under the purchase order. We are currently working with Stellantis to align on the remaining deliverables under this purchase order and are also engaged with Stellantis on a potential EV contactor program.

 

13

 

Customer Engagements

 

We have announced several engagements and/or initial orders with large companies, including Stellantis and other global automakers, Forbes Global 500 diverse power management market leaders, global tier 1 automotive suppliers, circuit protection market leaders, inverter / energy storage market leaders and others. Companies in our sales pipeline intend to test and evaluate, or are already in the process of testing and evaluating, our technology for use in their applications. These engagements could lead to future design wins or custom development agreements. We previously announced agreements with multiple distribution partners. We may add other distribution partners in the future. Earlier this year, we signed a letter of intent with an industry partner to co-develop a B-TRAN®-enabled intelligent solid-state circuit breaker (“SSCB”) prototype for evaluation by a U.S. hyperscaler in its development environment for the NVIDIA Rubin Ultra 800V direct current AI data center power distribution system. We may engage with others in the power semiconductor ecosystem in the future to further expand the channels to market for products incorporating our technology.

 

Collaboration

 

In October 2026, Power Integrations, Inc. (Nasdaq: POWI) announced a collaboration with us on solid-state circuit breakers providing ultra-fast, efficient, always-on protection that scales with the 800 VDC transition in AI data centers. The collaboration pairs our B-TRAN® with their 1700V InnoMux-2 power conversion integrated circuits to deliver self-powered intelligent SSCBs. We have demonstrated a working prototype and are working on a reference design for potential customers.

 

Results of Operations

 

Comparison of the three months ended September 30, 2026 to the three months ended September 30, 2025

 

Revenue. Revenue was $7,000 for the three months ended September 30, 2026, compared to $24,450 in the three months ended September 30, 2025. Revenue in the three months ended September 30, 2026 related to a stocking order for SSCB reference design kits from one of our distribution partners. Revenue in the three months ended September 30, 2025 related primarily to our completion of the first deliverable under the purchase order from Stellantis. See “Development Agreement” above.

 

Cost of Revenue. Cost of revenue was $9,768 for the three months ended September 30, 2026, compared to $26,069 in the three months ended September 30, 2025. Cost of revenue in the three months ended September 30, 2026 related to the cost of SSCB reference design kits shipped to one of our distribution partners. Cost of revenue in the three months ended September 30, 2025 related to the cost of the first deliverable under the purchase from Stellantis.

 

Research and Development Expenses. Research and development expenses increased by $34,906, or 2%, to $1,828,068 in the three months ended September 30, 2026 from $1,793,162 in the three months ended September 30, 2025. The increase was due to higher personnel costs of $245,447 and other B-TRAN® spending of $21,241, partly offset by lower semiconductor fabrication costs of $231,782. We expect relatively flat quarterly research and development expenses in the fourth quarter of 2026 as compared to the third quarter of 2026. There will be quarter-to-quarter variability in research and development expenses due to the timing of semiconductor fabrication runs, hiring and other development activities.

 

General and Administrative Expenses. General and administrative expenses increased by $654,917, or 68%, to $1,613,855 in the three months ended September 30, 2026 from $958,938 in the three months ended September 30, 2025. The increase was due to higher stock-based compensation expense of $267,608, professional fees of $147,197, non-cash patent impairment charges of $143,964, personnel costs of $79,920 and other costs of $16,228. We expect flat to modestly lower general and administrative expenses in the fourth quarter of 2026 as compared to the third quarter of 2026.

 

Sales and Marketing Expenses. Sales and marketing expenses increased by $208,512, or 78%, to $475,110 in the three months ended September 30, 2026 from $266,598 in the three months ended September 30, 2025. The increase was due to higher personnel costs of $188,829, travel costs of $44,154 and other spending of $22,873, partly offset by lower search and placement fees of $47,344. We expect higher quarterly sales and marketing expenses in the fourth quarter of 2026 as compared to the third quarter of 2026 due to anticipated hiring to further support our commercialization activities.

 

Loss from Operations. Our loss from operations for the three months ended September 30, 2026 was $3,919,801, or 30% higher, as compared to the $3,020,317 loss from operations for the three months ended September 30, 2025, for the reasons discussed above.

 

Interest Income, Net. Net interest income was $336,273 for the three months ended September 30, 2026, compared to $79,667 for the three months ended September 30, 2025, due primarily to the impact of a higher cash balance after the May 2026 Offering on interest earned on our money market accounts.

 

Net Loss. Our net loss for the three months ended September 30, 2026 was $3,583,528, or 22% higher, as compared to a net loss of $2,940,650 for the three months ended September 30, 2025, for the reasons discussed above.

 

14

 

Comparison of the nine months ended September 30, 2026 to the nine months ended September 30, 2025

 

Revenue. Revenue was $12,800 for the nine months ended September 30, 2026, compared to $37,728 in the nine months ended September 30, 2025. Revenue in the nine months ended September 30, 2026 related to a stocking order for SSCB reference design kits from one of our distribution partners and shipments under our purchase order from Stellantis. Revenue in the nine months ended September 30, 2025 related to our completion of certain deliverables under the purchase order from Stellantis as well as prototype product sales and revenue related to custom development of SSCB prototypes. We expect to recognize modest product and/or development revenue in the fourth quarter of 2026.

 

Cost of Revenue. Cost of revenue was $13,776 for the nine months ended September 30, 2026, compared to $60,408 in the nine months ended September 30, 2025. Cost of revenue in the nine months ended September 30, 2026 related to the cost of SSCB reference design kits shipped to one of our distribution partners and prototype products shipped under our purchase order from Stellantis. Cost of revenue in the nine months ended September 30, 2025 related primarily to the cost of the first deliverable under the purchase order from Stellantis as well as prototype product sales and revenue related to custom development of SSCB prototypes. We generally expect negative gross margin from product revenue at low volumes with significant improvement in gross margins as we commence higher volume production and shipments in the future. Development revenue may result in either positive or negative gross margin depending on our scope for any specific program.

 

Research and Development Expenses. Research and development expenses increased by $29,342, or less than 1%, to $5,290,515 in the nine months ended September 30, 2026 from $5,261,173 in the nine months ended September 30, 2025.

 

General and Administrative Expenses. General and administrative expenses increased by $1,735,840, or 63%, to $4,491,838 in the nine months ended September 30, 2026 from $2,755,998 in the nine months ended September 30, 2025. The increase was due to higher stock-based compensation expense of $965,687, non-cash patent impairment charges of $359,097, personnel costs of $294,441, professional fees of $90,863 and other spending of $25,752.

 

Sales and Marketing Expenses. Sales and marketing expenses increased by $505,851, or 53%, to $1,451,642 in the nine months ended September 30, 2026 from $945,791 in the nine months ended September 30, 2025. The increase was due to higher personnel costs of $416,091, travel costs of $127,363, stock-based compensation expense of $54,316 and other spending of $16,726, partly offset by lower search and placement fees of $108,645.

 

Loss from Operations. Our loss from operations for the nine months ended September 30, 2026 was $11,234,971, or 25% higher, as compared to the $8,985,642 loss from operations for the nine months ended September 30, 2025, for the reasons discussed above.

 

Interest Income, Net. Net interest income was $607,012 for the nine months ended September 30, 2026 compared to $305,203 for the nine months ended September 30, 2025 due primarily to the impact of a higher cash balance after the May 2026 Offering on interest earned on our money market accounts.

 

Net Loss. Our net loss for the nine months ended September 30, 2026 was $10,627,959, or 22% higher, as compared to a net loss of $8,680,439 for the nine months ended September 30, 2025, for the reasons discussed above.

 

Liquidity and Capital Resources

 

We have incurred losses since inception. We have funded our operations to date primarily through the sale of common stock and pre-funded warrants.

 

At September 30, 2026, we had cash and cash equivalents of $38.3 million. Our net working capital at September 30, 2026 was $37.1 million. We had no outstanding debt at September 30, 2026.

 

Operating activities in the nine months ended September 30, 2026 resulted in cash outflows of $7,226,693, which were due to the net loss for the period of $10,627,959, partly offset by stock-based compensation of $2,256,255, patent impairment charges of $393,459, favorable balance sheet timing of $380,507, depreciation and amortization of $295,587, and other non-cash items of $75,458.

 

Operating activities in the nine months ended September 30, 2025 resulted in cash outflows of $6,973,275, which were due to the net loss for the period of $8,680,439, partly offset by stock-based compensation of $997,840, depreciation and amortization of $276,332, favorable balance sheet timing of $328,510, and other non-cash items of $104,482.

 

We expect relatively flat cash outflows from operating activities in the fourth quarter of 2026 as compared to the third quarter of 2026 as we further commercialize our B-TRAN® technology.

 

Investing activities in the nine months ended September 30, 2026 and 2025 resulted in cash outflows of $512,467 and $376,738, respectively, for the acquisition of intangible assets and fixed assets.

 

15

 

Financing activities in the nine months ended September 30, 2026 resulted in cash inflows of $40,259,375 in net proceeds from the issuance and sale of common stock and pre-funded warrants and $267 from the exercise of pre-funded warrants, partly offset by $379,456 in tax payments related to the vesting of stock units.

 

Financing activities in the nine months ended September 30, 2025 resulted in net cash outflows of $98,724 with a cash outflow of $98,834 in tax payments related to the vesting of restricted stock units slightly offset by a cash inflow of $110 from the exercise of pre-funded warrants.

 

May 2026 Offering

 

In May 2026, we issued and sold 3,220,961 shares of our common stock at a price of $5.67 per share and 2,070,044 pre-funded warrants to purchase shares of common stock at a price of $5.669 per pre-funded warrant in a registered direct offering (the “May 2026 Offering”). The pre-funded warrants have an exercise price of $0.001 per share and no expiration date. The net proceeds to us from the May 2026 Offering were $27.7 million. We intend to use the net proceeds from the May 2026 Offering to fund further commercialization and development of our B-TRAN® technology and products and general corporate and working capital purposes.

 

February 2026 Offering

 

In February 2026, we issued and sold 3,505,855 shares of our common stock at a price of $2.75 per share and 952,881 pre-funded warrants to purchase shares of common stock at a price of $2.749 per pre-funded warrant in an underwritten public offering and also sold 631,332 pre-funded warrants to purchase shares of common stock at a price of $2.749 per pre-funded warrant in a concurrent private placement (taken together, the “February 2026 Offering”). The shares of common stock underlying the pre-funded warrants issued in the concurrent private placement were subsequently registered for resale on the Registration Statement on Form S-1 (File No. 333-294696) declared effective on April 3, 2026. The pre-funded warrants have an exercise price of $0.001 per share and no expiration date. The net proceeds to us from the February 2026 Offering were $12.6 million. We are utilizing the net proceeds from the February 2026 Offering to fund further commercialization and development of our B-TRAN® technology and products and general corporate and working capital purposes.

 

Critical Accounting Estimates

 

There have been no significant changes during the nine months ended September 30, 2026 to the critical accounting estimates disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

 

Trends, Events and Uncertainties

 

There are no material changes from trends, events or uncertainties disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

 

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company, we are not required to provide this information.

 

ITEM 4.  CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the Company’s reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. The Company’s disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that this information is accumulated and communicated to management, including the principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company conducted an evaluation (pursuant to Rule 13a-15(b) of the Exchange Act), under the supervision and with the participation of its Chief Executive Officer (principal executive officer) and its Chief Financial Officer (principal financial officer) of the effectiveness of the Company’s disclosure controls and procedures as of September 30, 2026 and has concluded that, as of September 30, 2026, the Company’s disclosure controls and procedures are effective.

 

16

 

Changes in Internal Control over Financial Reporting

 

There have been no material changes in our internal controls over financial reporting that occurred during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 

Limitations on the Effectiveness of Controls

 

Control systems, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any system of controls must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of error or mistake. Control systems can also be circumvented by the individual acts of some persons by collusion of two or more people, or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

 

PART II-OTHER INFORMATION

 

ITEM 1.  LEGAL PROCEEDINGS

 

We are subject to litigation from time to time. While we believe that any current or threatened legal proceedings are without merit and not material, there can be no assurance that such matters will not have a material adverse effect on our business, financial condition or results of operations in the future.

 

ITEM 1A.  RISK FACTORS

 

There are no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025.

 

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

 

Not applicable.

 

ITEM 4.  MINE SAFETY DISCLOSURES

 

Not applicable.

 

 

ITEM 5.  OTHER INFORMATION

 

During the three months ended September 30, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

 

17

 

ITEM 6.  EXHIBITS

 

Exhibit
Number

 

Document

     

31.1*

 

Certification of Principal Executive Officer pursuant to Exchange Act Rule, 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

     

31.2*

 

Certification of Principal Financial Officer pursuant to Exchange Act Rule, 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

     

32.1**

 

Certification pursuant to 18 U.S.C. 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

     

101.INS*

 

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

     

101.SCH*

 

Inline XBRL Taxonomy Extension Schema Document

     

101.CAL*

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

     

101.DEF*

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

     

10.LAB*

 

Inline XBRL Taxonomy Extension Label Linkbase Document

     

101.PRE*

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

     

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

 


*

Filed herewith

**

Furnished herewith

 

18

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Dated: November 16, 2026

IDEAL POWER INC.  

   
 

By:

/s/ David Somo

   

David Somo 

   

Chief Executive Officer  

     
 

By:

/s/ Timothy W. Burns  

   

Timothy W. Burns  

   

Chief Financial Officer  

 

19

Keep reading